Background and aims Unlike tobacco, the effect of marijuana smoke on subclinical atherosclerosis, a surrogate
INTRODUCTION
As marijuana use is increasingly legalized and prescribed for medical conditions, the public health community's interest in informing the public about potential health effects of marijuana use has also grown [1] . In 2013, annual prevalence of marijuana use was 7.5-9.4% in the US population [2, 3] . In 2014, up to 17% of the US population had smoked tobacco. Marijuana and tobacco smoke share many constituents [4] . Whereas the negative health effects of tobacco smoke are widely known [5] , according to the recent National Academy of Science report there is little information about possible adverse health consequences of marijuana, including the harm that prolonged and heavy use might cause to the cardiovascular system [6, 7] .
Computed tomography can detect atherosclerosis before clinical symptoms appear, which makes it a measure of subclinical atherosclerosis. Abdominal aorto-iliac calcium (AAC) and coronary artery calcium (CAC) scores are better predictors of incident coronary heart disease and cardiovascular disease (CVD) than standard risk factors and other well-known biomarkers [8, 9] . Tobacco smoke is a known cause of atherosclerosis and tobacco use is also a strong predictor of AAC and CAC [10] . However, we do not yet know if marijuana smoke also causes atherosclerosis, and we found only one previous prospective cohort study which has assessed the association between cumulative marijuana use and CAC [11] . Cumulative smoking and marijuana use were associated significantly with multiple plaque measures, but with negligible effect sizes for marijuana [11] . To the best of our knowledge, no previous study has tested the association between cumulative marijuana use and AAC.
On the basis of case reports, some have voiced concern that increased marijuana use may spur a new CVD epidemic [12] . Cohort studies can isolate more effectively the possible association of marijuana with CVD. A large cohort of 49 321 conscripted Swedish men aged 18-20 years at the time of inclusion and followed for 40 years found a trend towards increased risk of stroke in heavy marijuana smokers after multivariate adjustment [13] . However, investigators collected data on marijuana use only at the time of inclusion, which might have led to imprecise estimates of the true marijuana exposure and explain the null findings. In contrast, marijuana and tobacco smoking and other covariates associated with marijuana use and atherosclerosis have been measured repeatedly in CARDIA participants for 25 years.
We tested the association between cumulative marijuana use and ACC and CAC measures, and accounted for cumulative tobacco exposure and other measures associated with atherosclerosis and marijuana and tobacco use.
METHODS

Study design and sample
We used data collected during 25 years in the Coronary Artery Risk Development in Young Adults (CARDIA) study, a population-based epidemiological study of 5115 adults aged 18-30 years at baseline [14] . Participants were recruited in 1985 and 1986 by selecting telephone numbers randomly from designated census tracts in Birmingham, AL; Chicago, IL; Minneapolis, MN; and, by random selection from the membership list of a health care plan in Oakland, CA. The sampling scheme was designed to achieve equal proportions at each of the four sites by race (self-identified 'black, not Hispanic' and 'white, not Hispanic'), sex, education (up to a high school degree, education beyond high school) and age (18-24 years, 25-30 years). All subjects gave informed consent before entering the study and at each follow-up examination. The study was approved by institutional review boards for each site.
Marijuana and tobacco smoking exposure
Current marijuana use was assessed at each in-person CARDIA examination (at baseline and at 2, 5, 7, 10, 15, 20 and 25 years of follow-up) by the following survey question: 'During the last 30 days, on how many days did you use marijuana?'. Direct self-reported lifetime exposure was assessed by the question: ' About how many times in your lifetime have you used marijuana?'. We used current and lifetime use to compute marijuana-years: 1 year of exposure was equivalent to 365 days of marijuana use [15] . We assumed that current use at each survey (i.e. the number of days the participant used marijuana in the month before each survey) reflected the average number of days of use during the months between surveys. We estimated cumulative lifetime use by adding up the total number of days the participant used marijuana during the entire follow-up period. We adjusted our estimate upwards whenever participants self-reported higher lifetime use than we computed [15, 16] .
Cigarette smoking behavior was evaluated at each in-person CARDIA examination and at yearly phone follow-up between CARDIA examinations [15] . At baseline, participants were asked the total number of years they had smoked, the age at which they started smoking regularly ('How old were you when you started smoking cigarettes regularly?') and, if appropriate, years since cessation ('How many years ago did you stop?'). We used these data to estimate cumulative lifetime exposure to cigarettes in terms of pack-years: one pack-year of exposure was equivalent to 7300 cigarettes (1 year × 365 days/years × 1 pack/day × 20 cigarettes/pack) [15, 16] . Occasional smoking was not queried in CARDIA.
Outcome measures: coronary artery calcium and abdominal aortic calcium
The primary outcome variables were presence of CAC and AAC (total calcification score > 0 Agatston units) measured at year 25 [17] . We used computed tomography (CT) to assess subclinical coronary atherosclerosis [presence of any CAC or AAC at year 25 (2010-2011) ] [18] . To measure CAC, we obtained contiguous 2.5-3-mm-thick transverse images from the root of the aorta to the apex of the heart [19] . To measure AAC, we obtained 1-1.25-mm-thick transverse images 15 cm proximal to the superior end plate of the sacrum [19] . We measured calcium in the wall of the distal abdominal aorta in a 60-mm segment centered at the aortic bifurcation. Images collected at each center were then transmitted electronically to the CARDIA Reading Center [18] . Total CAC and AAC scores were calculated by image analysts blinded to participant characteristics; they used a modified Agatston method, with select over-reading by a physician expert in cardiovascular imaging.
Other covariates
We estimated cumulative years of exposure to passive smoking. We defined 1 year of exposure to passive smoking as the total number of hours exposed to passive smoking over 24 hours for 365 days (eMethods, Supporting information) [20] . We estimated lifetime alcohol consumption in 'drink-years'. We defined 1 drink-year as the amount of alcohol consumed by a person in 1 year of drinking one drink/day (eMethods, Supporting information) [15] . We defined acute heavy exposure to alcohol (bingeing) as five or more drinks consumed on one occasion, and we estimated total lifetime bingeing episodes. We estimated total number of lifetime exposures to cocaine (including crack, powder, free base), amphetamines (speed, uppers, methamphetamines), and heroin (eMethods, Supporting information) [15, 21] .
The highest educational grade attained for each participant was the measure of education. We measured physical activity with the CARDIA physical activity history questionnaire, which asks how much time per week the participant spent in 13 categories of leisure, occupational and household physical activities during the past 12 months [22] . We measured self-reported depressive symptoms every 5 years, starting at year 5, on the Center for Epidemiologic Studies Depression scale (CES-D) [23] . Our cardiovascular risk factor measurements included blood pressure, blood cholesterol [total, low-density lipoprotein (LDL), high-density lipoprotein (HDL) cholesterol and triglycerides], fasting glucose and body mass index (BMI), which were collected at each CARDIA examination (eMethods, Supporting information). We calculated cumulative exposures to cardiovascular risk factors, physical activity and depression symptoms (eMethods, Supporting information) [15, 24] .
Statistical analyses
We used descriptive statistics to compare participants with different levels of marijuana exposure at year 25. We then described unadjusted associations between lifetime marijuana use and the presence or absence of AAC or CAC. In our primary analysis, we used multinomial regression models to assess independent associations between years of exposure to marijuana. We compared three categories of subclinical atherosclerosis: (1) no AAC and no CAC; (2) any AAC and no CAC; and (3) CAC, regardless of AAC. We found that history of exposure to tobacco smoking interacted significantly with the association between cumulative exposure to marijuana and AAC, in both unadjusted and multivariate adjusted multinomial regression models (P < 0.1) (Supporting information, Table S2). We therefore stratified all results and analyses by history of exposure to tobacco smoking. First, we estimated unadjusted models. Then, we estimated multivariate adjusted models, controlling for covariates to achieve balanced sampling in CARDIA (age, race, sex, study site and years of education) and for covariates associated potentially with both marijuana and subclinical atherosclerosis (cigarette smoking, alcohol, cocaine, amphetamines and heroin, exposure to passive smoking, cardiovascular risk factors, physical activity, BMI, depression symptoms and diabetes). We used restricted cubic splines with three knots at the quartiles of their distributions to flexibly model marijuana-years of exposure, pack-years and years of exposure to passive smoking. We used inverse probability of censoring weights (IPCWs) to minimize potential bias by informative censoring (eMethods, Supporting information) [25, 26] . We tested whether sex and race interacted, and evaluated the sensitivity of the results to alternate strategies for modeling subclinical atherosclerosis using multivariate adjusted logistic regression models to contrast (a) participants with and without AAC, (b) those with and without CAC and (c) those with AAC and CAC and those with no AAC and no CAC. We tested sensitivity of the results to alternate modeling techniques: (1) a multivariate adjusted model that included an interaction term between history of exposure to tobacco smoking and cumulative exposure to marijuana; (2) a multivariate adjusted model that compared participants according to history of exposure to marijuana and tobacco, (a) no history of exposure to tobacco or marijuana, (b) history of exposure to tobacco and not to marijuana, (c) no history of exposure to tobacco and history of exposure to marijuana and (d) history of exposure to both tobacco and marijuana; and (3) a set of multivariate regressions that enabled us to model AAC and CAC as continuous measures (eMethods, Supporting information). We further evaluated the proportion of participants who might have been mixing tobacco with marijuana to smoke marijuana (mulling) at baseline by measuring blood cotinine levels, and we then tested the sensitivity of the results to excluding participants with cotinine levels suggestive of tobacco exposure and no self-reported use of tobacco at baseline (eMethods, Supporting information) [27] [28] [29] . Tests of statistical significance were two-tailed; alpha level was 0.05. All analyses were conducted with Stata version 14.2 (StataCorp LP, College Station, TX, USA).
RESULTS
Of the 3498 participants assessed at the year 25 visit, 3197 (91%) had data entries for AAC or CAC, and 3117 (89%) had complete AAC and CAC data (Supporting information, Figure S1 ). Attrition was more common among men, blacks, heavy marijuana users, tobacco smokers and cocaine users in multivariate adjusted analyses (eResults, Supporting information). In unadjusted analyses, attrition was associated with age, race, gender, education and smoking (Supporting information, Table S1 ). Most participants (n = 2627, 84%) reported having used marijuana before or during the 25 years of follow-up, but most had relatively few cumulative years of exposure (Table 1) . Among marijuana users, a minority (n = 156, 6%) reported having used marijuana every day in the month before a CARDIA examination. Among those, the median number of joints smoked per day at the year 10 examination was 2 (interquartile range = 1-3). In contrast, 1536 (49%) reported ever smoking tobacco daily. Cumulative exposure to tobacco was high; 42% of ever smokers reported smoking 10 pack-years. Total years of marijuana exposure was associated strongly with other participant characteristics, including race and sex, education, study site, other substance use, physical activity, BMI, HDL cholesterol and triglycerides and depressive symptoms (Table 1) . Among those who never smoked tobacco, 73% (n = 1155) were ever marijuana users; among ever tobacco smokers, 96% (n = 1472) were ever marijuana users (Table 1) .
Among those who never smoked tobacco, cumulative marijuana-years were associated with CAC in unadjusted analyses, but not with AAC (Table 2) . Multivariate adjusted multinomial models that categorized presence and absence of AAC and CAC into three categories: AAC = 0 and CAC = 0, AAC > 0 and CAC = 0, CAC > 0, regardless of AAC, revealed that lifetime exposure to marijuana was not associated AAC and CAC (Table 3 , Fig. 1a,b) . Only 26 participants were exposed to marijuana for 10 marijuana-years (equivalent to using marijuana every day for 10 years, or four a week for 14 years): their OR for CAC regardless of AAC was 1.63 [95% confidence internals (CI) = 0.81-3.29; Table 3 ].
Among those who ever smoked tobacco daily, cumulative marijuana-years were associated with AAC and CAC in unadjusted analyses (Table 2 ). In multivariate logistic regression models, at 1 year of exposure to marijuana the OR for AAC and no CAC was 1.36 (95% CI = 1.07-1.71) and CAC, regardless of AAC, was 1.29 (95% CI = 0.98-1.69; Table 3 , Fig. 1c,d ). In multivariate logistic regression models that compared AAC with no AAC, cumulative marijuana use was associated with AAC only among ever tobacco smokers (Table 4) . Sensitivity analyses demonstrated no evidence of significant interactions by race or sex (P > 0.10 for all tests). Results were similar when we included an interaction term between history of exposure to tobacco smoking and cumulative exposure to marijuana, instead of stratifying results by history of exposure to tobacco (Supporting information, Table S2 ). We found no association between AAC or CAC and history of exposure to marijuana among those with no history of exposure to tobacco, and found significant associations among those with history of exposure to marijuana and tobacco (Supporting information, Table S2 ). Modeling AAC or CAC as continuous outcomes resulted in OR similar to those returned by the main models (Supporting information, Table S4 ).
Tobacco smoking was associated strongly with both AAC and CAC in unadjusted and multivariate adjusted analyses. The OR at 10 pack-years of tobacco was 5.86 (95% CI = 3.64-9.45) for AAC and no CAC and 6.61 (95% CI = 3.92-11.14) for CAC regardless of AAC (Table 3 , Fig. 1e,f) .
Among participants who reported no tobacco smoking at baseline, 4% had cotinine levels suggestive of exposure to tobacco among those reporting no marijuana use within the last 30 days and 11% among those reporting marijuana use within the last 30 days (Supporting information, Table S5 ). Results were virtually unchanged when we excluded participants with cotinine levels suggestive of exposure to tobacco exposure and no self-reported use of tobacco (Supporting information, Table S6 ).
DISCUSSION
In this community-based cohort of young adults followed for 25 years, we found little or no significant association between cumulative marijuana use and either AAC or CAC. Among those who had never used tobacco, marijuana use was not associated significantly with AAC or CAC, but we identified a trend towards increased risk of AAC and CAC among those whose cumulative exposure to marijuana was high (5 marijuana-years, equivalent to smoking marijuana daily for 5 years). Among ever tobacco smokers, using marijuana daily for 5 years nearly doubled the odds of AAC and CAC. As expected, cumulative tobacco smoking exposure was associated strongly with both AAC and CAC. The vast majority of participants had been exposed to marijuana during their lifetime, but few had more than 365 days of cumulative exposure, and few used it daily. In contrast, half the participants reported that they had smoked tobacco daily, and most had smoked 20 cigarettes a day for at least 5 years.
Previous analyses of the participants in the CARDIA study showed no association between marijuana use and cardiovascular events, or mortality overall [30, 31] . One possibility for such lack of association was hypothesized (14) 947 (30) 208 (7) 64 (2) 787 (25) (26) 1 (2) 114 (14) 309 (45) Heroin, n (col. %) (Continues) to be due to the mean age of participants (approximately 50 years), which is younger than the age at which most CVD occurs. Therefore, our current study is able to provide timely insight into any relationship of marijuana with subclinical atherosclerosis.
We found only one previous study which had tested the association between CAC and cumulative marijuana use, and found no previous studies having tested the association with AAC [11] . The 1005 participants in the Multicenter AIDS Cohort Study (MACS) participants (621 HIV + and 384 HIV -) underwent non-contrast CT scanning to measure CAC when they were aged 54, on average. Participants were queried on self-reported use of substances at semiannual visits during 10 years. Cumulative pack-years of smoking and marijuana were associated significantly with multiple plaque measures, but with negligible effect sizes for marijuana [11] . Our null finding among never tobacco users could be explained by the opposing effects that By design, the CARDIA study sampled self-identified white men, white women, black men and black women in roughly equal numbers for participation in the study [42] . Cumulative lifetime exposure to cigarettes in terms of pack-years, with 1 pack-year of exposure equivalent to 7300 cigarettes (1 year × 365 days/year × 1 pack/days × 20 cigarettes/pack) (Methods) [16] . e Cumulative lifetime exposure to second-hand cigarette smoke in terms of years of second-hand smoking exposure with 1 year of exposure equivalent to 8700 hours of exposure (1 year × 365 days/year × 24 hours per day) (Methods) [20] . f Drink-years among those reporting ever drinking alcohol. A drink-year was defined as the total amount of ethanol consumed by a person who had had one alcoholic drink per day for 1 year (1 drink-year = 17.24 ml of ethanol/drink × 1 drink/day × 365 days/year = 6292.6 ml of ethanol). The number of days on the illicit drug listed over the study duration was computed using current exposure (current use defined as any use within the last 30 days) at each visit and replaced by lifetime exposure when the latter was higher. Cocaine included other forms of cocaine, such as crack, powder, free base; amphetamines included speed, uppers and methamphetamines (Methods and eMethods, Supporting information).
i Physical activity measured with the CARDIA physical activity history questionnaire, which queries the amount of time per week spent in 13 categories of leisure, occupational and household physical activities over the past 12 months [22] . j Calculated as weight in kilograms divided by height in meters squared. k Depression symptoms was measured every 5 years starting at the year 5 visit by using the Center for Epidemiologic Studies Depression scale (CES-D) [23] . A score of ≥ 16 used as the cut-off value for both sexes as an indication of the clinically significant depressive symptoms [43] . l Cumulative lifetime exposure to marijuana joints in terms of marijuana-years, with 1 marijuana-year of exposure equivalent to 365 days used marijuana (1 year × 365 days/year) (see Methods and eMethods, Supporting information) [16, 44] . Table 2 Association between lifetime exposure to marijuana and measures of subclinical atherosclerosis among never and ever tobacco users, Coronary Artery Risk Development in Young Adults (CARDIA), year 25. (100) 426 (100) 947 (100) 208 (100) 1536 (100) 64 (100) 787 (100) 685 (100) 3 categories, n (col %) AAC = 0 and CAC = 0 1246 (40) 770 (49) 211 (50) 478 (50) 81 (39) 476 (31) 26 (41) 279 (35) 171 (25) AAC > 0 and CAC = 0 982 (32) 432 (27) 123 (29) 252 (27) 57 (27) 0.005 550 (36) 15 (23) 283 (36) 252 (37) < 0.001 CAC > 0, regardless of AAC 889 (29) 379 (24) 92 (22) 217 (23) 70 (34) 510 (33) 23 (36) 225 (29) 262 (38) 2 categories (binary outcome) AAC > 0, n (% compared to AAC = 0) 1663 (53) 679 (43) 187 (44) 394 (41) 98 (47) 0.3
984 (64) 32 (50) 473 (60) 479 (70) < 0.001 CAC > 0, n (% compared to CAC = 0) 889 (29) 379 (24) 92 (22) 217 (23) 70 (34) 0.002 510 (33) 23 (36) 225 (29) 262 (38) < 0.001
to AAC = 0 and CAC = 0)
1871 (60) 811 (51) 215 (50) 469 (50) 127 (61) 0.01 1060 (69) 38 (59) 508 (65) 514 ( marijuana may have on atherosclerosis [32] . Besides the combustion constituents of marijuana smoke [4] , the main component of marijuana smoke is tetrahydrocannabinol (THC), which activates the CB 2 and CB 1 receptors of the endocannabinoid system. Activating the CB 2 receptor might protect marijuana smokers from developing atherosclerosis, as this regulates inflammatory cells and been shown to reduce atherosclerosis in mice [33] . Conversely, activating the CB 1 receptor might increase atherosclerosis [34] , as inhibiting CB 1 might protect against atherosclerosis [35, 36] . The trend toward increasing atherosclerosis that we found among those whose cumulative exposure to marijuana was high might be caused by combustion constituents of marijuana smoke other than THC [4, 37] . In the CARDIA cohort, cumulative marijuana exposure was low among those who had used the drug-much lower than cumulative tobacco exposure among ever tobacco users. Our null findings might thus also be explained by the low intensity of marijuana use in our cohort. It remains possible that smoking marijuana every day for many years could cause as much harm as smoking tobacco cigarettes. Acute exposure to marijuana might have negative effects on heart disease, as it can increase heart rate and could trigger arrhythmias by activating the CB 1 receptor and precipitating a myocardial infarction (MI) [38, 39] . The acute effect of marijuana might explain one study's finding of a surge in MI just after marijuana use [39] . The absence of evidence of an increase in subclinical atherosclerosis in our study and the absence of significant association with CVD events in previous analyses in CARDIA [30] suggest that even if marijuana can trigger an acute MI, it is does not increase the atherosclerotic process that leads to MI. Multinomial logistic regression models with three categories of subclinical atherosclerosis: (1) no AAC and no CAC; (2) any AAC and no CAC; and (3) CAC, regardless of AAC as the outcome and cumulative exposure to marijuana or tobacco smoking modeled as restricted cubic splines, stratified by history of exposure to tobacco smoking (Methods). b Models adjusted for age, race, sex, study site, years of education, cumulative and current exposure to licit and illicit substances such as cigarette smoking, alcohol, cocaine, amphetamines and heroin, exposure to passive smoking, cardiovascular risk factors, physical activity, BMI, depression symptoms and diabetes (Methods). Analyses weighted by the inverse probability of censoring (IPCW) to address potential bias by informative censoring (eMethods, Supporting information). Our study also has some limitations. We found that cumulative marijuana use was associated significantly with ACC among ever tobacco smokers, but we cannot rule out residual confounding by tobacco smoking. Tobacco smokers who use marijuana might also be more likely to smoke a mix of tobacco and marijuana ('mulling') [28, 29] . When we explored the associations between blood cotinine levels based on self-reported exposure to Figure 1 Associations between cumulative exposures to marijuana and tobacco and abdominal artery calcium (AAC) and coronary artery calcium (CAC). Multivariate adjusted multinomial logistic regression models showing an absence of association between higher exposure to marijuana and greater odds of AAC > 0 and CAC = 0 (a) and CAC > 0, regardless of ACC (b) compared to AAC = 0 and CAC = 0 among never tobacco smokers. Among ever tobacco smokers, models show a significant association between higher exposure to marijuana for AAC > 0 and CAC = 0 (c), but not for CAC > 0, regardless of ACC (d) compared to AAC = 0 and CAC = 0. For tobacco pack-years of exposure, models show a significant and dose-response association for both AAC > 0 and CAC = 0 (e), and CAC > 0, regardless of ACC (f) compared to AAC = 0 and CAC = 0. Scale of the axis presenting the odds ratio multiplied by 10 to present the association with tobacco pack-years. Multivariate models adjusted for covariates potentially associated with marijuana, tobacco and subclinical atherosclerosis: age, race, sex, study site, years of education, exposure to illicit and licit substances (alcohol, cocaine, amphetamines and heroin use, exposure to passive smoking), cardiovascular risk factors, physical activity, body mass index (BMI), depression symptoms, and diabetes (Methods). Analyses were weighted by the inverse probability of censoring (IPCW) to address potential bias by informative censoring (eMethods in Supporting information). (a,b) Marijuana-years among never tobacco smokers (n = 1581). (c,d) Marijuana-years among ever tobacco smokers (n = 1536). (e,f) Tobacco pack-years among ever smokers (n = 1536) tobacco and marijuana smoking, we found 7% of participants not reporting smoking tobacco might have been mulling at baseline (11% in those not reporting currently using marijuana versus 4% in those reporting currently using marijuana). Blood cotinine was measured only at baseline, so we cannot estimate the prevalence of mulling over follow-up or estimate the amount of mulling among participants who reported tobacco use. Our marijuana exposure measurements are derived from self-reports, which are less reliable than blood or urine tests. Marijuana use was measured infrequently; examinations can be up to 5 years apart, and this reduced the precision of the estimates. CARDIA also did not ask how old participants were when they began using marijuana, so we only could estimate exposure before the start of the study by looking at participants' own estimates of the number of times they had been exposed to marijuana.
Our study was strengthened by extensive adjustment for a wide range of potential confounders, and by particularly detailed data on primary and secondary tobacco exposure and other licit and illicit drug exposures. We also used advanced methods to adjust for cardiovascular risk factors in our models of cumulative exposures. The proportion of participants followed for up to 25 years was high, and our statistical methods took into account potential informative censoring [25, 26] . Although it was difficult to adjust fully for tobacco exposure, because many participants said they had not smoked tobacco during their lifetime, we could test the association in those who only used marijuana. We had data on AAC and CAC scores, which are among the strongest predictors of incident coronary heart disease [8, 40, 41] .
Our results apply mainly to occasional, recreational users of marijuana whose exposure is low overall. Larger studies with longer follow-up are needed to confirm the absence or presence of association between marijuana and subclinical atherosclerosis and CVD events. It would be useful to explore the trend towards increased odds of AAC and CAC with high cumulative use of only marijuana, based on data from large cohorts, rigorous measures and extensive follow-up. If the trend is real this may have implications for medical marijuana users, as they often use marijuana daily over many years. These studies are needed urgently to inform medical marijuana patients and prescribers about possible CVD risks associated with smoking medical marijuana.
Marijuana and tobacco use were both common, but the intensity of lifetime tobacco smoking was consistently much higher than marijuana. Cumulative marijuana use was not associated with measures of atherosclerosis among middle-aged adults never exposed to tobacco, but we saw a trend towards increased risk of atherosclerosis among those with very high exposure to marijuana. These results should be interpreted carefully, as few participants had such high exposure. Among those who had used tobacco, we found a small but significant association between marijuana use and AAC, even after we adjusted extensively for tobacco smoke exposure, but this may have been due to residual confounding. Our study confirms the strong and consistent association between tobacco use and both AAC and CAC; the broader public health implications of high prevalence of tobacco use among marijuana users is alarming.
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